These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28877884)

  • 21. Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.
    Suzuki R; Fukui T; Kishimoto M; Miyamoto S; Takahashi Y; Takeo M; Mitsuyama T; Sakaguchi Y; Uchida K; Nishio A; Okazaki K
    J Crohns Colitis; 2015 Jul; 9(7):565-74. PubMed ID: 25908723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclin E.
    Lai W; Tang Y; Huang XR; Ming-Kuen Tang P; Xu A; Szalai AJ; Lou TQ; Lan HY
    Kidney Int; 2016 Sep; 90(3):610-26. PubMed ID: 27470679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
    Wu C; Chen W; Fang M; Boye A; Tao X; Xu Y; Hou S; Yang Y
    J Ethnopharmacol; 2019 Mar; 231():98-112. PubMed ID: 30412748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region.
    Jeon WK; Choi J; Park SJ; Jo EJ; Lee YK; Lim S; Kim JH; Letterio JJ; Liu F; Kim SJ; Kim BC
    Oncotarget; 2015 Dec; 6(39):41650-66. PubMed ID: 26497676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.
    Murata M; Yoshida K; Yamaguchi T; Matsuzaki K
    World J Gastroenterol; 2014 Nov; 20(41):15018-27. PubMed ID: 25386050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
    Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
    Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells.
    Matsuzaki K
    Cell Tissue Res; 2012 Jan; 347(1):225-43. PubMed ID: 21626291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smad3 C-terminal phosphorylation site mutation attenuates the hepatoprotective effect of salvianolic acid B against hepatocarcinogenesis.
    Gong Y; Li D; Li L; Yang J; Ding H; Zhang C; Wen G; Wu C; Fang Z; Hou S; Yang Y
    Food Chem Toxicol; 2021 Jan; 147():111912. PubMed ID: 33290806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystin genetic variants cause autosomal recessive polycystic kidney disease associated with altered Myc expression.
    Yang C; Harafuji N; O'Connor AK; Kesterson RA; Watts JA; Majmundar AJ; Braun DA; Lek M; Laricchia KM; Fathy HM; Mane S; Shril S; Hildebrandt F; Guay-Woodford LM
    Sci Rep; 2021 Sep; 11(1):18274. PubMed ID: 34521872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene.
    Gattone VH; MacNaughton KA; Kraybill AL
    Anat Rec; 1996 Jul; 245(3):488-99. PubMed ID: 8800407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-182 inhibits kidney fibrosis by regulating transforming growth factor β1/Smad3 pathway in autosomal dominant polycystic kidney disease.
    Sun L; Hu C; Wang Z; Zhang X
    IUBMB Life; 2020 Jul; 72(7):1340-1348. PubMed ID: 32067333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions.
    Yoshida K; Murata M; Yamaguchi T; Matsuzaki K; Okazaki K
    J Clin Med; 2016 Jan; 5(1):. PubMed ID: 26771649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis.
    Suwa K; Yamaguchi T; Yoshida K; Murata M; Ichimura M; Tsuneyama K; Seki T; Okazaki K
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31991602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.
    Trudel M; Lanoix J; Barisoni L; Blouin MJ; Desforges M; L'Italien C; D'Agati V
    J Exp Med; 1997 Dec; 186(11):1873-84. PubMed ID: 9382886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The absence of prostaglandin e1 returned confluent cultures of highly proliferative murine polycystic kidney principal cells to a normal proliferation level.
    Orellana SA; Quinones AM
    In Vitro Cell Dev Biol Anim; 2003; 39(5-6):199-203. PubMed ID: 12875614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro-Tumorigenic Switch of TGFβ Signaling in Prostate Cancer.
    Majumder S; Bhowal A; Basu S; Mukherjee P; Chatterji U; Sengupta S
    J Cell Physiol; 2016 Nov; 231(11):2482-92. PubMed ID: 26919443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl
    Yang J; Gong Y; Xu W; Li L; Shi Z; Wang Q; He Y; Zhang C; Luo C; Fang Z; Yang Y
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1779-1786. PubMed ID: 34191114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astragaloside IV suppresses migration and invasion of TGF-β
    Li L; Wang Q; He Y; Sun L; Yang Y; Pang X
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Apr; 395(4):397-405. PubMed ID: 35092472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
    Zhang C; Li L; Hou S; Shi Z; Xu W; Wang Q; He Y; Gong Y; Fang Z; Yang Y
    J Ethnopharmacol; 2021 Oct; 279():114350. PubMed ID: 34157326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease.
    Li LX; Zhang L; Agborbesong E; Zhang X; Zhou JX; Li X
    Am J Physiol Renal Physiol; 2022 Aug; 323(2):F227-F242. PubMed ID: 35759739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.